What is the expected growth forecast for the BMAS market

The BMAS market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the BMAS market

Increasing demand for minimally invasive procedures drives the BMAS market.

What are the major challenges facing the BMAS market

High production costs and limited awareness are major challenges for the BMAS market.

Which regions are leading the BMAS market

North America and Europe are leading the BMAS market due to high adoption rates.

Who are the top companies in the BMAS market

Top companies include Medtronic and Abbott Laboratories, driving innovation in the BMAS market.

What future opportunities exist for the BMAS market

Emerging economies and growing demand for biodegradable materials offer future opportunities.

How does technology impact the BMAS market

Advances in material science and 3D printing technology are transforming the BMAS market.

What is the current regulatory landscape for the BMAS market

Stringent regulatory frameworks and safety standards govern the BMAS market.

What is the future outlook for the BMAS market

The future outlook is promising, with increasing adoption and growing demand expected.

Biodegradable Metal Alloy Stent (BMAS) Trends, Opportunities & Forecast 2033

Biodegradable Metal Alloy Stent (BMAS) by Application (Cardiovascular System, Digestive System, Respiratory System), by Types (Magnesium-based Alloys, Iron-based Alloys, Nickel-titanium Alloys, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Biodegradable Metal Alloy Stent (BMAS) Market Overview

The Biodegradable Metal Alloy Stent (BMAS) market refers to the industry involved in the development and distribution of biodegradable metal alloy stents, which are used in medical procedures to treat conditions such as coronary artery disease. As the biodegradable metal alloy stent market size is expected to experience significant growth, understanding the growth outlook, market forecast, and industry expansion is crucial for stakeholders. The scope of this market encompasses the production and sales of BMAS, including various types such as iron-based, magnesium-based, and zinc-based stents, across different applications and end-users. According to recent estimates, the current Biodegradable Metal Alloy Stent (BMAS) market size is approximately $1.4 billion.

Loading chart…

The biodegradable metal alloy stent market is expected to experience a CAGR of around 12% during the forecast period, driven by macro drivers such as the increasing prevalence of cardiovascular diseases, growing demand for minimally invasive procedures, and advancements in technology. Key forces shaping the industry include technology shifts towards more biocompatible materials, regulations governing the use of biodegradable materials, and competitive intensity among market players. The largest region in the BMAS market is currently North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing healthcare expenditure and growing awareness about biodegradable metal alloy stents.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Biotronik; ELLA-CS; Cardionovum; Bilakhia Groups; LifeTech Scientific; SINOMED; Lepu Medical Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Biodegradable Metal Alloy Stent (BMAS) market is poised for significant growth, driven by increasing demand for minimally invasive medical procedures and advancements in biodegradable technologies. The Biodegradable Metal Alloy Stent (BMAS) market size is expected to expand substantially, with a promising growth forecast.

Growth Drivers2 items

Advances in biodegradable materials and technologies are driving innovation in the Biodegradable Metal Alloy Stent (BMAS) market, enabling the development of more effective and durable stents. This is expected to boost the Biodegradable Metal Alloy Stent (BMAS) market size and contribute to its growth forecast.

Increasing preference for minimally invasive procedures among patients and healthcare providers is fueling the demand for Biodegradable Metal Alloy Stent (BMAS), further driving the market's growth forecast and expanding its market size.

Restraints2 items

High development costs and stringent regulatory requirements are significant restraints in the Biodegradable Metal Alloy Stent (BMAS) market, potentially hindering its growth forecast and limiting the expansion of its market size.

Limited reimbursement coverage for Biodegradable Metal Alloy Stent (BMAS) procedures in certain regions may restrict market growth, affecting the overall Biodegradable Metal Alloy Stent (BMAS) market size and growth forecast.

Opportunities2 items

Emerging economies present significant opportunities for the Biodegradable Metal Alloy Stent (BMAS) market, driven by growing healthcare infrastructure and increasing demand for advanced medical devices, which is expected to contribute to the growth forecast and expand the market size.

Collaborations between manufacturers, researchers, and healthcare providers can facilitate the development of innovative Biodegradable Metal Alloy Stent (BMAS) products, driving the growth forecast and increasing the Biodegradable Metal Alloy Stent (BMAS) market size.

Challenges2 items

Ensuring the biocompatibility and long-term safety of Biodegradable Metal Alloy Stent (BMAS) is a significant challenge, requiring rigorous testing and clinical trials, which can impact the growth forecast and market size.

Intense competition in the Biodegradable Metal Alloy Stent (BMAS) market may lead to pricing pressures, affecting the profitability of manufacturers and influencing the overall Biodegradable Metal Alloy Stent (BMAS) market size and growth forecast.

Market Segmentation

Loading chart…

The Application segment of the Biodegradable Metal Alloy Stent (BMAS) market refers to the various uses of BMAS in medical procedures. This segment is crucial in understanding the Biodegradable Metal Alloy Stent (BMAS) segmentation and its impact on the overall market size. The application segment includes coronary arteries, peripheral arteries, and carotid arteries, among others. Each application contributes to the market size, with coronary arteries being the largest contributor due to the high prevalence of coronary artery diseases.

The Types segment of the BMAS market is categorized into subtypes, including magnesium-based, iron-based, and zinc-based alloys. This segmentation is vital in understanding the market taxonomy and the growth prospects of each subtype. Magnesium-based alloys are the most widely used due to their high biodegradability and biocompatibility. The types segment contributes to the overall market size, with each subtype having a significant share. Understanding the types segment is essential for industry players to develop targeted strategies and products.

Biodegradable Metal Alloy Stent (BMAS) Segmentation Breakdown9 items

Application

Cardiovascular System

Digestive System

Respiratory System

Types

Magnesium-based Alloys

Iron-based Alloys

Nickel-titanium Alloys

Other

Regional Insights

Loading chart…

The Biodegradable Metal Alloy Stent (BMAS) market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of BMAS, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: for North America, high demographics of cardiovascular disease, mature ecosystem for BMAS, and significant investments in research and development. For Europe, stringent policies and regulations, increasing adoption of BMAS, and a well-established infrastructure for healthcare. For Asia Pacific, large and growing demographics, increasing investments in healthcare, and favorable policies for BMAS adoption. For Latin America, growing demographics, increasing adoption of BMAS, and improving infrastructure for healthcare. For Middle East & Africa, growing demographics, increasing investments in healthcare, and favorable policies for BMAS adoption.

The regional forecast indicates that Asia Pacific will experience the highest growth rate, driven by the aforementioned factors. The Biodegradable Metal Alloy Stent (BMAS) market is expected to continue growing globally, with each region contributing to the overall growth, driven by increasing adoption, favorable policies, and significant investments in healthcare infrastructure.

Competitive Landscape

The Biodegradable Metal Alloy Stent (BMAS) market is moderately consolidated, driven by a mix of global players and local/regional companies. The Biodegradable Metal Alloy Stent (BMAS) competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies emphasize distribution and pricing strategies.

Companies employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To mitigate these risks, companies focus on technology, service model, channel strength, customization, and cost advantages. The following companies have adopted distinct strategic focuses:

Biotronik: regional expansion

ELLA-CS: vertical integration

Cardionovum: premium pricing

Bilakhia Groups: OEM tie-ups

LifeTech Scientific: innovation pipeline

SINOMED: local manufacturing

Key Biodegradable Metal Alloy Stent (BMAS) Companies7 items

Biotronik

ELLA-CS

Cardionovum

Bilakhia Groups

LifeTech Scientific

SINOMED

Lepu Medical Technology

Market Ecosystem

The Biodegradable Metal Alloy Stent (BMAS) ecosystem encompasses a complex network of participants, spanning from upstream raw material suppliers to downstream end users. This ecosystem can be broadly categorized into three stages: upstream, where technology providers and suppliers create value through innovation and raw material provision; midstream, where integrators and manufacturers transform these inputs into BMAS products; and downstream, where channels and end users ultimately capture value through product adoption and usage.

Raw material/component suppliers — provide essential materials

OEMs / manufacturers — design and produce BMAS products

Technology providers — develop underlying alloy technologies

System integrators / EPCs — integrate BMAS into medical systems

Distributors / channel partners — facilitate product distribution

Regulators/standards bodies — establish safety and efficacy standards

End users / buyers — adopt and use BMAS products in medical procedures

In the BMAS ecosystem, value flows through the creation and capture of innovative products that meet stringent medical standards. Control points, such as regulatory approvals and technology patents, influence adoption rates and market entry barriers. Dependency risks, including input material constraints and changing regulatory standards, can impact the ecosystem's stability. Furthermore, as the BMAS ecosystem differs by region due to varying regulatory environments and market demands, participants must navigate these complexities to ensure successful partnerships, interoperability, and ultimately, the delivery of life-saving medical products, which is a key aspect of conducting a thorough value chain analysis.

Recent Industry Insights

The Biodegradable Metal Alloy Stent (BMAS) industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on advancing research and development of novel BMAS materials. Notably, several mergers and acquisitions have taken place, aiming to consolidate expertise and expand product portfolios. Furthermore, innovative product launches have showcased enhanced biocompatibility and biodegradability features, aligning with evolving regulatory requirements. A shift in consumer preferences towards more sustainable and minimally invasive medical solutions has also been observed, driving demand for BMAS solutions.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Biodegradable Metal Alloy Stent (BMAS) market outlook. The market attractiveness is moderate, driven by growing demand for minimally invasive medical procedures and increasing awareness of the benefits of biodegradable materials. The competitive intensity is high, with several key players investing in research and development to improve product offerings.

The long-term outlook for the BMAS market is positive, with innovation in materials and technologies expected to drive growth. The demand–supply balance is currently stable, but may shift as new products enter the market. Key risk factors include regulatory challenges and high development costs. Overall, the BMAS market presents opportunities for growth and innovation, but requires careful navigation of the competitive landscape.

12 items

1. Executive Summary

2. Biodegradable Metal Alloy Stent (BMAS) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Biodegradable Metal Alloy Stent (BMAS) Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Biodegradable Metal Alloy Stent (BMAS) Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Biodegradable Metal Alloy Stent (BMAS) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Biodegradable Metal Alloy Stent (BMAS) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Biodegradable Metal Alloy Stent (BMAS) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Biodegradable Metal Alloy Stent (BMAS) Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Biodegradable Metal Alloy Stent (BMAS) Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Biodegradable Metal Alloy Stent (BMAS) Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Biodegradable Metal Alloy Stent (BMAS) Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Biodegradable Metal Alloy Stent (BMAS) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Biodegradable Metal Alloy Stent (BMAS) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Biodegradable Metal Alloy Stent (BMAS) Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Biodegradable Metal Alloy Stent (BMAS) Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Biodegradable Metal Alloy Stent (BMAS) Market Competition by Key Manufacturers

9.1. Global Biodegradable Metal Alloy Stent (BMAS) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Biodegradable Metal Alloy Stent (BMAS): Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Biotronik

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. ELLA-CS

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Cardionovum

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Bilakhia Groups

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. LifeTech Scientific

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. SINOMED

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Lepu Medical Technology

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Biodegradable Metal Alloy Stent (BMAS) Market

Figure 4: Global Biodegradable Metal Alloy Stent (BMAS) Market: Drivers

Figure 5: Global Biodegradable Metal Alloy Stent (BMAS) Market: Challenges

Figure 6: Global Biodegradable Metal Alloy Stent (BMAS) Market: Trends

Figure 7: Global Biodegradable Metal Alloy Stent (BMAS) Market: Opportunity

Figure 8: Global Biodegradable Metal Alloy Stent (BMAS) Market: Restraint

Figure 9: Global Biodegradable Metal Alloy Stent (BMAS) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Biodegradable Metal Alloy Stent (BMAS) Market Value (USD Million) By Region

Figure 19: Global Biodegradable Metal Alloy Stent (BMAS) Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Biodegradable Metal Alloy Stent (BMAS) Market Value (USD Million) By Region

Figure 27: Global Biodegradable Metal Alloy Stent (BMAS) Market Share (%) By: Regions (2032)

Figure 28: Global Biodegradable Metal Alloy Stent (BMAS) Market Volume (K) By Region

Figure 29: Global Biodegradable Metal Alloy Stent (BMAS) Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Biodegradable Metal Alloy Stent (BMAS) Market Value (USD Million) By Region

Figure 37: Global Biodegradable Metal Alloy Stent (BMAS) Market Share (%) By: Regions (2032)

Figure 38: Global Biodegradable Metal Alloy Stent (BMAS) Market Volume (K) By Region

Figure 39: Global Biodegradable Metal Alloy Stent (BMAS) Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

109 items

Table 1: Market Segmentation Analysis

Table 2: Global Biodegradable Metal Alloy Stent (BMAS) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Biodegradable Metal Alloy Stent (BMAS) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Biodegradable Metal Alloy Stent (BMAS) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Biodegradable Metal Alloy Stent (BMAS) Market Value (USD Million) By Region

Table 14: Global Biodegradable Metal Alloy Stent (BMAS) Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Biodegradable Metal Alloy Stent (BMAS) Market Volume (K) By Region

Table 31: Global Biodegradable Metal Alloy Stent (BMAS) Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Biodegradable Metal Alloy Stent (BMAS) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Biodegradable Metal Alloy Stent (BMAS) Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Biodegradable Metal Alloy Stent (BMAS) Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Biotronik Basic Information And Sales Area

Table 52: Biotronik. Products Portfolio

Table 53: ELLA-CS Basic Information And Sales Area

Table 54: ELLA-CS. Products Portfolio

Table 55: Cardionovum Basic Information And Sales Area

Table 56: Cardionovum. Products Portfolio

Table 57: Bilakhia Groups Basic Information And Sales Area

Table 58: Bilakhia Groups. Products Portfolio

Table 59: LifeTech Scientific Basic Information And Sales Area

Table 60: LifeTech Scientific. Products Portfolio

Table 61: SINOMED Basic Information And Sales Area

Table 62: SINOMED. Products Portfolio

Table 63: Lepu Medical Technology Basic Information And Sales Area

Table 64: Lepu Medical Technology. Products Portfolio

Table 65: Global Market Value (USD Million) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Value (USD Million) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Market Volume (K) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Volume (K) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Biodegradable Metal Alloy Stent (BMAS) Market Value (USD Million) By Region

Table 74: Global Biodegradable Metal Alloy Stent (BMAS) Market Share (%) By Region (2025-2032)

Table 75: North America Market Value (USD Million) (2025-2032) By Country

Table 76: North America Market Value (USD Million) (2025-2032) By Application

Table 77: North America Market Value (USD Million) (2025-2032) By Types

Table 78: Europe Market Value (USD Million) (2025-2032) By Country

Table 79: Europe Market Value (USD Million) (2025-2032) By Application

Table 80: Europe Market Value (USD Million) (2025-2032) By Types

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 84: South America Market Value (USD Million) (2025-2032) By Country

Table 85: South America Market Value (USD Million) (2025-2032) By Application

Table 86: South America Market Value (USD Million) (2025-2032) By Types

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 90: Global Biodegradable Metal Alloy Stent (BMAS) Market Volume (K) By Region

Table 91: Global Biodegradable Metal Alloy Stent (BMAS) Market Share (%) By Region (2025-2032)

Table 92: North America Market Volume (K) (2025-2032) By Country

Table 93: North America Market Volume (K) (2025-2032) By Application

Table 94: North America Market Volume (K) (2025-2032) By Types

Table 95: Europe Market Volume (K) (2025-2032) By Country

Table 96: Europe Market Volume (K) (2025-2032) By Application

Table 97: Europe Market Volume (K) (2025-2032) By Types

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 99: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 101: South America Market Volume (K) (2025-2032) By Country

Table 102: South America Market Volume (K) (2025-2032) By Application

Table 103: South America Market Volume (K) (2025-2032) By Types

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 105: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 107: Research Programs/Design For This Report

Table 108: Key Data Information From Secondary Sources

Table 109: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Biodegradable Metal Alloy Stent (BMAS) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Biotronik; ELLA-CS; Cardionovum; Bilakhia Groups; LifeTech Scientific; SINOMED; Lepu Medical Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Biodegradable Metal Alloy Stent (BMAS) Segmentation Breakdown9 items

Application

Cardiovascular System

Digestive System

Respiratory System

Types

Magnesium-based Alloys

Iron-based Alloys

Nickel-titanium Alloys

Other

Regional Insights

Loading chart…

Competitive Landscape

Biotronik: regional expansion

ELLA-CS: vertical integration

Cardionovum: premium pricing

Bilakhia Groups: OEM tie-ups

LifeTech Scientific: innovation pipeline

SINOMED: local manufacturing

Key Biodegradable Metal Alloy Stent (BMAS) Companies7 items

Biotronik

ELLA-CS

Cardionovum

Bilakhia Groups

LifeTech Scientific

SINOMED

Lepu Medical Technology

Market Ecosystem

Raw material/component suppliers — provide essential materials

OEMs / manufacturers — design and produce BMAS products

Technology providers — develop underlying alloy technologies

System integrators / EPCs — integrate BMAS into medical systems

Distributors / channel partners — facilitate product distribution

Regulators/standards bodies — establish safety and efficacy standards

End users / buyers — adopt and use BMAS products in medical procedures

Recent Industry Insights

Analyst Overview

Table of Contents